Skip to content

Gross Profit at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$84.1M-37.1%
Opko Health logo
Opko HealthOPK
$45.76M+7.4%
Merck & Co. logo
Merck & Co.MRK
$12.09B-0.2%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's gross profit?
SIGA Technologies (SIGA) reported gross profit of $3.3M in Q1 2026.
How has SIGA Technologies's gross profit changed year-over-year?
SIGA Technologies's gross profit decreased by 52.0% year-over-year, from $6.88M to $3.3M.
What is the long-term trend for SIGA Technologies's gross profit?
Over 4 years (2021 to 2025), SIGA Technologies's gross profit has grown at a -13.7% compound annual growth rate (CAGR), from $117.07M to $64.87M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.